The scientist’s investigation covers issues in Internal medicine, Surgery, Arthritis, Physical therapy and Pediatrics. His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Immunology. His study in Surgery is interdisciplinary in nature, drawing from both Juvenile dermatomyositis, Dermatomyositis, Connective tissue disease and Radiology.
His work is dedicated to discovering how Arthritis, Intensive care medicine are connected with Outcomes research and other disciplines. His work deals with themes such as Juvenile, Oligoarthritis, Quality of life, Severity of illness and Juvenile Arthritis Disease Activity Score, which intersect with Physical therapy. His Pediatrics research is multidisciplinary, incorporating perspectives in Cohort study and Cohort.
His primary scientific interests are in Internal medicine, Arthritis, Surgery, Immunology and Rheumatology. Many of his studies on Internal medicine apply to Gastroenterology as well. His research integrates issues of Dermatology and Physical therapy in his study of Arthritis.
Surgery and Juvenile dermatomyositis are frequently intertwined in his study. The study incorporates disciplines such as Retrospective cohort study and Family medicine in addition to Rheumatology. His work focuses on many connections between Disease and other disciplines, such as Pediatrics, that overlap with his field of interest in Cohort.
His primary areas of investigation include Internal medicine, Rheumatology, Disease, Arthritis and Dermatology. He combines Internal medicine and Childhood arthritis in his research. Ronald M. Laxer interconnects Methotrexate, Randomized controlled trial, Retrospective cohort study, Family medicine and Comparative effectiveness research in the investigation of issues within Rheumatology.
Ronald M. Laxer has included themes like Autoantibody and Haploinsufficiency in his Disease study. His work deals with themes such as Juvenile, Systematic review, Quality of life, Physical therapy and Transplantation, which intersect with Arthritis. His study in the field of Acne and Localized Scleroderma is also linked to topics like Chromosome 15.
His main research concerns Internal medicine, Disease, Rheumatology, Family medicine and Cancer research. His research ties Vaccination and Internal medicine together. The concepts of his Disease study are interwoven with issues in Presentation, Pediatrics and Retrospective cohort study.
In his work, Familial Mediterranean fever is strongly intertwined with Severity of illness, which is a subfield of Rheumatology. His Cancer research study combines topics in areas such as Phenotype, Missense mutation, Chemokine, Necroptosis and Proinflammatory cytokine. His biological study deals with issues like Prospective cohort study, which deal with fields such as Dermatology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features
Timothy Beukelman;Nivedita M. Patkar;Kenneth G. Saag;Sue Tolleson-Rinehart.
Arthritis Care and Research (2011)
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
Scott W. Canna;Adriana Almeida de Jesus;Sushanth Gouni;Stephen R. Brooks.
Nature Genetics (2014)
Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study
F. Zulian;B. H. Athreya;R. Laxer;A. M. Nelson.
Medical Treatment of Juvenile Idiopathic Arthritis
Philip J. Hashkes;Ronald M. Laxer.
Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease
Qing Zhou;Hongying Wang;Daniella M. Schwartz;Monique Stoffels.
Nature Genetics (2016)
Localized scleroderma in childhood is not just a skin disease.
Francesco Zulian;Cristina Vallongo;Patricia Woo;Ricardo Russo.
Arthritis & Rheumatism (2005)
CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome.
Jose Marcelino;John D. Carpten;Wafaa M. Suwairi;Orlando M. Gutierrez.
Nature Genetics (1999)
2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications
Sarah Ringold;Pamela F. Weiss;Timothy Beukelman;Esi Morgan DeWitt.
Arthritis & Rheumatism (2013)
Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up.
Adam M. Huber;Pei-Yoong Lam;Catherine M. Duffy;Rae S.M. Yeung.
The Journal of Pediatrics (2002)
Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study
R. K. Saurenmann;A. V. Levin;B. M. Feldman;J. B. Rose.
Arthritis & Rheumatism (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: